Communicable Diseases  >>  stavudine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

10 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
stavudine / Generic mfg.
D4T, NCT02670772: Dose Optimisation of Stavudine for the Treatment of HIV Infection

Completed
3b
1077
RoW
Stavudine, d4t, Tenofovir Disoproxil Fumarate, TDF
Willem Daniel Francois Venter, Bill and Melinda Gates Foundation
Acquired Immune Deficiency Syndrome, Human Immunodeficiency Virus
12/14
12/15
NCT00002246: A Study to Evaluate the Use of Stavudine (d4T) to Treat AIDS Dementia Complex

Completed
3
20
US, Europe, RoW
Stavudine
Bristol-Myers Squibb
AIDS Dementia Complex, HIV Infections
03/99
03/99
NCT00002224: Comparison of Two Anti-HIV Regimens That Include One of Two Forms of Didanosine (ddI)

Completed
3
120
US, Canada
Nelfinavir mesylate, Stavudine, Didanosine
Bristol-Myers Squibb
HIV Infections
03/99
03/99
NCT00002429: Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen

Completed
3
500
US, Canada
Lamivudine/Zidovudine, Nelfinavir mesylate, Stavudine, Didanosine
Bristol-Myers Squibb
HIV Infections
01/01
01/01
NCT00158821: Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.

Completed
3
180
US
Viread (tenofovir disoproxil fumarate), Viread, Sustiva (Efavirenz), Sustiva, Epivir (Lamivudine), Epivir, Zerit (Stavudine) Placebo, Zerit
Gilead Sciences
HIV Infections
12/01
06/13
NCT00005918: Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients

Completed
3
730
US, Canada, Europe, RoW
Efavirenz, Lamivudine, Stavudine
Bristol-Myers Squibb
HIV Infections
04/02
04/02
NCT00116298: Rollover Study for Zerit (Stavudine) ER Studies (-096, -099)

Completed
3
900
US, Canada, Europe, RoW
stavudine, efavirenz, lamivudine
Bristol-Myers Squibb
HIV Infections, AIDS
01/05
01/05
NCT00135369: Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen

Completed
3
300
US
stavudine extended-release, lamivudine, efavirenz
Bristol-Myers Squibb
HIV Infections
07/05
07/05
NCT00528957 / 2007-003418-32: Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children

Completed
3
97
US, Europe, RoW
Tenofovir DF, Viread®, Zidovudine, Stavudine
Gilead Sciences
HIV Infections
04/09
08/17
NCT00006154: A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection

Completed
3
165
Canada
Indinavir sulfate, IDV, Ritonavir, RTV, Abacavir sulfate, ABC, Efavirenz, DMP, Stavudine, d4T, Didanosine, ddI, Aldesleukin, Proleukin, IL-2
National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
 
 

Download Options